Thyroid Storm

Table of Contents

1. Overview
2. Epidemiology and Mortality
3. Precipitating Triggers
4. Pathophysiology
5. Clinical Presentation and Burch-Wartofsky Scoring
6. Diagnosis
7. Emergency Treatment — The 5-Drug Approach
8. Specific Therapies in Detail
9. Supportive Care and Intensive Care Unit Management
10. Prevention and Long-Term Management
11. Key Research Papers
12. Connections
13. Featured Videos

Overview

Thyroid storm — also called thyrotoxic crisis — is a life-threatening exacerbation of hyperthyroidism that causes decompensation of multiple organ systems simultaneously. It is one of the true emergencies in endocrinology, carrying a mortality rate of 10–30% even with optimal modern treatment. Historically, before effective intensive care, mortality reached 80%.

Thyroid storm is rare: roughly 1–2 cases per million people per year in the general population, accounting for approximately 1–2% of patients hospitalized with hyperthyroidism. Despite its rarity, failure to recognize and treat it within hours is lethal, which makes early identification and immediate empirical treatment essential — treatment guidelines start therapy without waiting for lab confirmation.

The defining feature is not simply very high thyroid hormone levels. Rather, thyroid storm occurs when the body's compensatory mechanisms break down under the combined burden of excessive thyroid hormone and an acute physiological stressor. The heart, brain, liver, and thermoregulatory system all fail together. The most commonly encountered underlying cause is Graves disease, and the storm is almost always triggered by a superimposed event — surgery, infection, iodine load, or another acute illness.

Immediate intensive care unit (ICU) admission and simultaneous initiation of a five-drug treatment protocol are the cornerstones of management.

Back to Table of Contents

Epidemiology and Mortality

Thyroid storm affects an estimated 500–2,000 people per year in the United States. It is more common in women than men, directly reflecting the sex distribution of hyperthyroidism and Graves disease, which predominantly affect women of reproductive age.

Mortality has improved dramatically over the decades. Before the development of antithyroid drugs, beta-blockers, and modern intensive care, mortality exceeded 80%. Today, with prompt recognition and aggressive multi-drug treatment, mortality ranges from 10–30%. Some specialized centers with very early intervention report rates at the lower end of that range.

The leading causes of death in thyroid storm are:

• Cardiac arrhythmias — particularly atrial fibrillation with rapid ventricular response leading to hemodynamic collapse
• Multi-organ failure — renal failure, hepatic failure, and adrenal crisis occurring together
• Congestive heart failure — initially high-output failure transitioning to low-output cardiogenic shock
• Hyperthermia-related complications — extreme fever driving further catecholamine release and cardiovascular stress

Age matters: elderly patients with pre-existing cardiac disease tolerate the cardiac demands of thyroid storm far less well and carry higher mortality. A nationwide Japanese survey (Akamizu et al., 2012) found a mortality rate of more than 10% (11.0% and 9.5% in its two grades of thyroid storm), with multiple organ failure the most common cause of death, followed by congestive heart failure, respiratory failure and arrhythmia.

Back to Table of Contents

Precipitating Triggers

Thyroid storm almost never occurs out of nowhere. The formula is almost always: pre-existing hyperthyroidism + acute precipitant. Identifying the precipitant is critical because treating it is a mandatory part of storm management — leaving the trigger untreated will make recovery far harder.

Infection (Most Common in Modern Series)

Any infection can precipitate thyroid storm: pneumonia, urinary tract infection, sepsis, dental abscess, influenza. Infection triggers increased catecholamine release and directly stimulates thyroid hormone secretion. In contemporary series, infection has replaced surgery as the most frequent precipitant because pre-operative preparation of hyperthyroid patients is now standard of care.

Surgery

Historically the most common trigger. Thyroid surgery in a patient who has not been rendered euthyroid is the classic scenario. Any major surgery — not only thyroid — can precipitate storm in an uncontrolled hyperthyroid patient. The physiological stress of surgery amplifies the already-elevated catecholamine sensitivity. Modern endocrinology protocols mandate euthyroid status before elective thyroid surgery.

Radioactive Iodine (RAI) Treatment

Radiation thyroiditis following RAI administration can cause a temporary dump of preformed thyroid hormone into the circulation. In patients with severe or poorly controlled hyperthyroidism, this transient surge can trigger storm. Current guidelines recommend pretreatment with antithyroid drugs (and often beta-blockers) in high-risk patients — those with severe hyperthyroidism, the elderly, or patients with cardiac disease — before RAI administration.

Iodine Load — Jod-Basedow Phenomenon

An acute iodine load can trigger thyroid storm in susceptible patients. Sources include:

• Iodinated contrast dye used during computed tomography (CT) scans or cardiac catheterization
• Amiodarone — the antiarrhythmic drug contains approximately 37–40% iodine by weight; a single 200 mg tablet releases ~7,400 mcg of iodine (the daily requirement is 150 mcg)
• Iodine-containing cough syrups, topical antiseptics (povidone-iodine), kelp supplements

The Jod-Basedow phenomenon specifically refers to iodine-induced hyperthyroidism in a patient with an autonomous nodule or iodine-deficient background thyroid gland.

Acute Medical Events

Myocardial infarction, stroke, diabetic ketoacidosis, severe trauma, burns, and labor and delivery have all been documented as precipitants. The physiological stress response amplifies thyroid hormone effects.

Abrupt Discontinuation of Antithyroid Drugs

Patients who abruptly stop propylthiouracil (PTU) or methimazole without medical supervision can experience rebound worsening of hyperthyroidism severe enough to trigger storm.

Palpation of the Thyroid

Vigorous examination of an enlarged, inflamed thyroid gland in a severely hyperthyroid patient can mechanically squeeze preformed hormone out of follicles. This is rare but documented.

Sympathomimetic Drugs

Pseudoephedrine, amphetamines, and other sympathomimetics worsen the catecholamine hypersensitivity that characterizes thyroid storm and can precipitate crisis in borderline patients.

Back to Table of Contents

Pathophysiology

A key observation that puzzled clinicians for decades: thyroid hormone levels in storm are often not dramatically higher than in uncomplicated hyperthyroidism. This tells us that the storm is not simply about the amount of thyroid hormone — it is about a breakdown in adaptation.

Increased Free Hormone Availability

During acute illness, serum albumin and thyroid-binding globulin (TBG) levels fall rapidly. Because most T4 and T3 circulate bound to these proteins, a drop in binding capacity means more free hormone is available to enter cells. A patient who was compensated with a certain total T4 level can suddenly have a surge in biologically active free T4 simply because an intercurrent illness reduced their binding protein capacity.

Catecholamine Hypersensitivity

Thyroid hormone upregulates beta-adrenergic receptor density and sensitizes those receptors to catecholamines. In thyroid storm, this creates a vicious amplification loop: the precipitant (infection, surgery, stress) releases catecholamines → the already-sensitized adrenergic system overreacts → tachycardia, fever, and agitation worsen → more catecholamine release → cycle continues.

Impaired Thermoregulation

Thyroid hormone dramatically increases basal metabolic rate by uncoupling oxidative phosphorylation in mitochondria — essentially running the body's engines hot and generating excess heat. In storm, this thermoregulatory failure produces temperatures above 40°C (104°F). Extreme hyperthermia itself then drives further catecholamine release and accelerates the cardiac demands, compounding the crisis.

Cardiac Decompensation

The heart in hyperthyroidism is initially in a high-output state: increased heart rate, increased stroke volume, decreased systemic vascular resistance. This can initially maintain blood pressure and perfusion. However, sustained tachycardia — particularly above 140 bpm — severely limits diastolic filling time, reducing cardiac output. Combined with the high metabolic oxygen demands of storm, this leads to myocardial ischemia and eventually low-output cardiogenic shock. Atrial fibrillation, which occurs in 25–40% of thyroid storm cases, further impairs cardiac efficiency.

Relative Adrenal Insufficiency

Thyroid hormone accelerates cortisol metabolism. The adrenal glands may struggle to increase production fast enough to meet the storm's demands, resulting in a state of relative cortisol insufficiency. This is why glucocorticoids are a mandatory component of storm treatment — they replace cortisol and independently block peripheral conversion of T4 to the more active T3.

Back to Table of Contents

Clinical Presentation and Burch-Wartofsky Scoring

Thyroid storm presents as a syndrome of multi-system crisis. No single finding is pathognomonic, but the combination of high fever, tachycardia, altered mental status, and a known or newly discovered hyperthyroid state in the context of a recent precipitant is highly characteristic.

Fever — The Hallmark

Fever is almost invariably present and is one of the most diagnostically important features distinguishing storm from uncomplicated hyperthyroidism. Temperatures of 38.5–40°C (101–104°F) are typical; temperatures above 41°C (106°F) are ominous signs of severe disease. Profuse diaphoresis accompanies the fever. Salicylates (aspirin) are not used for fever in thyroid storm — they displace thyroid hormone from binding proteins, acutely raising free T4 levels and worsening the crisis. Acetaminophen (paracetamol) is the fever reducer that guidelines use instead.

Cardiovascular Manifestations

Tachycardia is nearly universal — heart rates above 140 bpm are common and expected. The tachycardia is disproportionate to the degree of fever. Atrial fibrillation occurs in 25–40% of patients and carries a high risk of thromboembolic stroke in this hypercoagulable, volume-depleted state. The pulse pressure is characteristically widened. Heart failure may be present — initially as high-output failure (warm extremities, bounding pulses), but deteriorating to low-output failure (cool extremities, hypotension, cardiogenic shock) in severe cases.

Neuropsychiatric Features

Central nervous system involvement ranges from mild agitation and anxiety to frank psychosis, delirium, tremor, seizures, and coma. Neuropsychiatric symptoms correlate with severity — the more profound the central nervous system (CNS) dysfunction, the worse the prognosis. Extreme restlessness and confusion in a patient with a rapid heart rate and fever is a classic pointer toward thyroid storm.

Gastrointestinal and Hepatic Involvement

Nausea, vomiting, diarrhea, and diffuse abdominal pain are common. Hepatic involvement — manifesting as jaundice and elevated liver enzymes — is a particularly ominous sign. Jaundice in thyroid storm indicates either direct thyroid hormone toxicity to hepatocytes or hepatic congestion from right heart failure.

Features of Underlying Hyperthyroidism

Examination may reveal a thyroid goiter (especially in Graves disease), exophthalmos (proptosis), pretibial myxedema, lid lag, and lid retraction. These findings point to the underlying etiology, but their absence does not exclude storm — particularly in elderly patients with "apathetic hyperthyroidism" who may present without the classic hyperadrenergic features.

Burch-Wartofsky Point Scale (BWPS)

The Burch-Wartofsky Point Scale, published in 1993, remains the most widely used clinical scoring system for diagnosing thyroid storm and stratifying its severity. Points are assigned across five domains:

Thermoregulatory Dysfunction

• Temperature 37.2–37.7°C (99–99.9°F) = 5 points
• Temperature 37.8–38.2°C (100–100.7°F) = 10 points
• Temperature 38.3–38.8°C (100.9–101.8°F) = 15 points
• Temperature 38.9–39.4°C (102–103°F) = 20 points
• Temperature 39.4–39.9°C (103–103.8°F) = 25 points
• Temperature ≥40°C (≥104°F) = 30 points

Central Nervous System Dysfunction

• Mild agitation = 10 points
• Delirium, psychosis, or extreme lethargy = 20 points
• Seizure or coma = 30 points

Gastrointestinal-Hepatic Dysfunction

• Diarrhea, nausea, vomiting, or abdominal pain = 10 points
• Unexplained jaundice = 20 points

Cardiovascular Dysfunction

• Heart rate 90–109 bpm = 5 points
• Heart rate 110–119 bpm = 10 points
• Heart rate 120–129 bpm = 15 points
• Heart rate 130–139 bpm = 20 points
• Heart rate ≥140 bpm = 25 points
• Atrial fibrillation = 10 additional points
• Mild congestive heart failure (pedal edema) = 5 points
• Moderate CHF (bibasilar rales) = 10 points
• Severe CHF (pulmonary edema) = 15 points

Precipitant Status

• Precipitating event absent = 0 points
• Precipitating event present = 10 points

Interpretation

• Score ≥45: Highly suggestive of thyroid storm
• Score 25–44: Suggestive of impending storm
• Score <25: Unlikely to represent thyroid storm

The BWPS is intentionally sensitive rather than specific — it is designed to catch storm rather than to rule it out, so in practice borderline scores are usually treated.

Back to Table of Contents

Diagnosis

Thyroid storm is a clinical diagnosis. Hospitals start treatment on the clinical picture and the BWPS score, without waiting for laboratory results.

Thyroid Function Tests

Thyroid-stimulating hormone (TSH) will be dramatically suppressed, typically below 0.01 mU/L (undetectable). Free T4 and free T3 will be elevated. Total T3 above 200 ng/dL (normal <180 ng/dL) is characteristic of thyroid storm. However, a critical caveat: some patients in thyroid storm have thyroid hormone levels only modestly above the upper limit of normal for hyperthyroidism. Thyroid storm is defined by the clinical syndrome, not by the magnitude of hormone elevation. Normal thyroid hormone levels do not exclude the diagnosis.

Laboratory Workup for Complications and Precipitants

• Complete blood count (CBC): leukocytosis (infection), anemia
• Comprehensive metabolic panel: electrolytes, glucose (both hypo- and hyperglycemia occur), renal function, liver enzymes, bilirubin
• Calcium: hypercalcemia can occur in thyrotoxicosis
• Blood cultures: to identify infectious precipitant; empirical antibiotics may be warranted if infection is suspected
• Troponin: demand-ischemia myocardial injury from sustained tachycardia is common
• BNP or NT-proBNP: elevated in heart failure
• Coagulation studies: disseminated intravascular coagulation can occur in severe cases

Electrocardiogram

Sinus tachycardia is the most common finding. Atrial fibrillation with rapid ventricular response occurs in 25–40% of cases. ST-segment changes and T-wave abnormalities from demand ischemia may be present. Rarely, complete heart block has been described.

Chest X-Ray

Pulmonary edema, cardiomegaly, and pleural effusions may be visible. The chest X-ray also helps identify pneumonia as a precipitating infection.

Distinguishing Thyroid Storm from Other Diagnoses

The differential diagnosis includes sepsis (look for source; thyroid-stimulating hormone distinguishes), neuroleptic malignant syndrome (exposure to antipsychotics; elevated creatine kinase), malignant hyperthermia (anesthesia exposure), pheochromocytoma (episodic paroxysms; catecholamine levels), and severe anticholinergic toxicity (dry skin vs. the diaphoresis of thyroid storm).

Back to Table of Contents

Emergency Treatment — The 5-Drug Approach

Thyroid storm requires simultaneous, immediate treatment targeting multiple steps in the thyroid hormone pathway. The five-drug approach addresses: (1) adrenergic symptoms, (2) new hormone synthesis, (3) existing hormone release, (4) peripheral T4-to-T3 conversion, and (5) the underlying precipitant. Protocols give the drugs in a specific sequence — the order matters.

Step 1: Beta-Blockers — Given First

Beta-adrenergic blockade provides the fastest clinical improvement, and protocols start it before any other drug. Beta-blockers control the life-threatening tachycardia, reduce the risk of atrial fibrillation with rapid ventricular rate, and lower the risk of thyroid-storm-induced cardiac death. Crucially, propranolol also blocks the peripheral conversion of T4 to the more active T3 — a mechanism unique among beta-blockers.

• Propranolol (preferred): 60–80 mg orally every 4–6 hours; or 0.5–1 mg intravenous (IV) given slowly (cardiac monitoring required) with repeated small doses titrated to heart rate below 100 bpm
• Esmolol intravenous infusion: when oral route is unavailable; highly titratable with an extremely short half-life (9 minutes), making it ideal for hemodynamically unstable patients
• Caution in heart failure: if the patient is in decompensated low-output heart failure, negative inotropy can worsen hemodynamics; lower doses or rate-controlling calcium channel blockers (diltiazem, verapamil) are the alternatives used
• Contraindication: reactive airway disease (asthma, severe chronic obstructive pulmonary disease, COPD) — diltiazem or verapamil are the alternatives used for rate control

Step 2: Thionamides — Block New Hormone Synthesis

Thionamides block the thyroid peroxidase enzyme, preventing the synthesis of new thyroid hormone. They do not affect the large stores of preformed hormone already in the gland. Their benefit takes days to weeks to fully manifest as existing hormone is cleared, which is why protocols start them immediately.

• Propylthiouracil (PTU): 500–1,000 mg oral or nasogastric loading dose, then 250 mg every 4–6 hours. Some guidelines have preferred PTU over methimazole in thyroid storm because PTU also inhibits the peripheral conversion of T4 to T3 (methimazole does not). A 2023 study of 1,383 critically ill patients found no significant difference in deaths or adverse events between PTU and methimazole, and the 2026 European joint consensus statement notes that this theoretical advantage has not translated into clear superiority in outcome studies.
• Methimazole: 60–80 mg/day in divided doses; the 2026 European consensus describes this dose as appearing to have equivalent efficacy to PTU in thyroid storm. Methimazole is generally preferred for long-term management (less hepatotoxicity than PTU) but lacks the T4→T3 conversion-blocking property. It is linked to birth defects when taken in the first trimester of pregnancy (choanal atresia, aplasia cutis), which is the situation in which guidance keeps PTU first.

Step 3: Inorganic Iodine — Block Hormone Release (Give AFTER Thionamides)

This is the most timing-critical step. Inorganic iodine, given in large doses, exploits the Wolff-Chaikoff effect — a transient inhibition of thyroid hormone synthesis and release triggered by acute iodine excess. It also inhibits proteolysis of thyroglobulin, reducing release of stored T3 and T4 from the gland.

The critical rule: protocols give iodine at least 1 hour after the thionamide dose. If iodine is given before or simultaneously with the thionamide, it provides substrate for new hormone synthesis before the synthesis machinery has been blocked — potentially worsening the crisis. The 2026 European consensus calls this 1-hour delay essential.

• Saturated solution of potassium iodide (SSKI): 5 drops (250 mg) orally every 6 hours
• Lugol's solution (5% iodine + 10% potassium iodide): 8–10 drops orally every 6–8 hours (the 2026 European consensus gives 8 drops four times a day)
• Alternative if iodine allergy: lithium carbonate 300 mg every 8 hours (inhibits hormone release through a different mechanism)

Step 4: Glucocorticoids — Block Peripheral Conversion and Address Adrenal Insufficiency

Glucocorticoids serve two roles in thyroid storm: they independently inhibit peripheral conversion of T4 to T3 (the same mechanism as PTU and propranolol), and they treat the relative adrenal insufficiency that develops because thyroid storm accelerates cortisol metabolism faster than the adrenal glands can compensate.

• Hydrocortisone: 100 mg intravenous every 8 hours (also provides mineralocorticoid activity; preferred if adrenal insufficiency is a major concern)
• Dexamethasone: 2 mg intravenous every 6 hours (potent T4→T3 conversion inhibitor; higher glucocorticoid potency per mg)

Step 5: Treat the Precipitant and Provide Aggressive Supportive Care

Guidelines treat the precipitating cause aggressively alongside the hormonal management. If infection is the trigger, broad-spectrum antibiotics are started immediately, even before cultures return. If the trigger is iodine load, the source is removed. Supportive care is detailed in the following section.

Back to Table of Contents

Specific Therapies in Detail

Beyond the five-drug core protocol, several additional interventions are available for refractory thyroid storm or for patients who cannot tolerate standard therapy.

Cholestyramine

Cholestyramine is a bile acid sequestrant resin that, when taken orally, binds thyroid hormone in the gut and prevents enterohepatic recirculation. Thyroid hormones are normally secreted into bile, partially reabsorbed from the intestine, and returned to systemic circulation. Cholestyramine interrupts this cycle, reducing circulating hormone levels as an adjunct to the standard protocol. Typical dose: 4 g orally four times daily. It is given well separated from other oral medications because it binds many drugs non-specifically.

Plasmapheresis and Plasma Exchange

Plasmapheresis physically removes thyroid hormone from the bloodstream by processing the patient's plasma through an extracorporeal filter. It is reserved for refractory thyroid storm — patients who are deteriorating despite maximal doses of all five standard drug classes. Plasma exchange can produce rapid, dramatic falls in circulating T3 and T4 levels within hours. Case series have shown clinical improvement in patients who had failed standard therapy. The procedure requires specialized equipment and expertise and is available at major medical centers.

Lithium

Lithium inhibits thyroid hormone release from the gland through mechanisms independent of iodine. It is used as an alternative to inorganic iodine in patients with documented iodine allergy. Serum lithium levels are monitored closely because the therapeutic window is narrow and toxicity (tremor, confusion, cardiac arrhythmia) occurs at levels only modestly above therapeutic.

Amiodarone — Controversial

Amiodarone's role in thyroid storm is paradoxical. On one hand, it is rich in iodine (40% by weight) and can theoretically worsen hyperthyroidism — indeed, amiodarone-induced thyrotoxicosis is itself a recognized cause of thyroid storm. On the other hand, some centers have used it in thyroid storm complicated by refractory atrial fibrillation, accepting the iodine load in exchange for its rate-controlling and antiarrhythmic properties. This remains controversial and is used only by specialist teams.

Emergency Thyroidectomy

Surgical removal of the thyroid is considered in the rare patient with refractory thyroid storm who continues to deteriorate despite maximal medical therapy. The gland is the source of the hormone driving the crisis, and removing it definitively eliminates that source. However, operating on a hemodynamically unstable, febrile, coagulopathic patient carries extreme surgical risk. The decision is made case by case by senior endocrinology and surgery teams. Medical stabilization before surgery — even partial — significantly improves operative outcomes.

Digoxin in Atrial Fibrillation

In patients with thyroid storm and atrial fibrillation who have decompensated heart failure precluding safe beta-blocker use, digoxin can be used for rate control. It is worth noting that thyrotoxicosis reduces digoxin sensitivity — higher than usual doses may be required to achieve rate control, and dose requirements will decrease as the patient becomes euthyroid.

Back to Table of Contents

Supportive Care and Intensive Care Unit Management

Thyroid storm is managed in intensive care. Patients with a BWPS score ≥45, and most patients with scores 25–44, are cared for in an intensive care unit or high-dependency unit with continuous cardiac monitoring. The following supportive measures are as important as the drug treatment.

Fever Management

Active cooling is a core part of care. Strategies include:

• Acetaminophen: the only safe antipyretic in thyroid storm; dose 650 mg every 4–6 hours. Aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated — salicylates displace thyroid hormone from binding proteins, acutely raising free T4 levels.
• Cooling blankets and ice packs to the axillae, groins, and neck
• Intravenous cool fluids (also addresses volume depletion)
• Evaporative cooling with a fan if severe hyperthermia persists

Volume Resuscitation

Patients in thyroid storm are profoundly volume depleted from massive insensible losses — high fever, diaphoresis, vomiting, diarrhea, and tachypnea all contribute. Aggressive intravenous fluid resuscitation (typically normal saline or balanced crystalloid) is standard. Dextrose is added to intravenous fluids because the hypermetabolic state rapidly depletes glycogen stores and hypoglycemia can occur.

Cardiac Management

• Continuous electrocardiogram (ECG) monitoring: mandatory for detecting arrhythmia
• Atrial fibrillation: rate control is the priority — cardioversion is rarely effective until the patient becomes euthyroid, and the ventricular rate will revert spontaneously with hormone control. The 2026 European consensus states that anticoagulation decisions follow standard stroke-risk scoring (such as the CHA2DS2-VASc score), weighed against bleeding risk, noting that many patients return to normal rhythm once thyroid levels are normal.
• Heart failure: gentle diuresis for pulmonary edema, since aggressive diuresis further depletes already-low intravascular volume; if low-output failure develops, vasopressors in the intensive care unit are used rather than aggressive beta-blocker dose increases

Nutrition

The hypermetabolic state of thyroid storm creates enormous caloric demands. Oral nutrition is maintained where possible. If the patient is encephalopathic, confused, or at risk of aspiration, early nasogastric tube placement for enteral nutrition is appropriate. Total parenteral nutrition is reserved for cases where enteral feeding is not feasible.

Thiamine Supplementation

In patients with any possibility of alcoholism, malnutrition, or prolonged illness, thiamine (vitamin B1) 100 mg intravenous is given before glucose to prevent precipitation of Wernicke's encephalopathy. This is a standard intensive care unit practice.

Deep Vein Thrombosis Prophylaxis

Thyroid storm creates a prothrombotic state: high-output cardiac physiology, immobility, potential atrial fibrillation, and volume shifts all raise venous thromboembolism risk. Pharmacological deep vein thrombosis (DVT) prophylaxis (low molecular weight heparin or unfractionated heparin) is standard unless there is a contraindication.

Monitoring the Response to Treatment

Clinical improvement — particularly falling heart rate and improving mental status — is usually apparent within 24–48 hours of initiating the full protocol. Thyroid hormone levels will fall more slowly because the large pool of preformed hormone in the gland and bound to serum proteins must clear. Free T4 typically normalizes over 5–7 days. The full drug protocol continues until the patient is clearly improving and stable, then is gradually tapered to maintenance antithyroid therapy.

Back to Table of Contents

Prevention and Long-Term Management

The best treatment for thyroid storm is ensuring it never occurs. This requires identifying and adequately treating hyperthyroidism before surgical or other physiological stressors.

Pre-Operative Preparation

Standard practice is to bring any patient with known hyperthyroidism — from any cause — to normal thyroid levels (euthyroid) before elective surgery. The standard pre-operative protocol includes:

• Antithyroid drug therapy (methimazole or PTU) for 4–8 weeks until thyroid-stimulating hormone is normal
• Lugol's solution 8–10 drops three times daily for 10 days immediately before surgery (reduces vascularity of the gland and prevents perioperative hormone surge)
• Beta-blocker (typically propranolol) to ensure heart rate control throughout the perioperative period

Pre-Treatment Before Radioactive Iodine

High-risk patients — those with severe hyperthyroidism (T4 very elevated), advanced age, or significant cardiac disease — are given antithyroid drugs to lower thyroid hormone levels before RAI administration in standard practice. Beta-blockade is usually maintained during the weeks after RAI to manage the transient worsening that occurs as radiation thyroiditis releases stored hormone.

Patient and Caregiver Education

Patient education for people with known Graves disease or other causes of hyperthyroidism covers:

• The warning signs of impending storm: rapidly worsening symptoms, especially high fever with rapid heartbeat and confusion
• The danger of abruptly stopping antithyroid medications
• The importance of informing any treating physician (including emergency providers) of their thyroid condition before procedures or iodine-containing contrast studies
• Carrying a medical alert card or bracelet indicating hyperthyroidism or Graves disease

Definitive Treatment of Hyperthyroidism

Eliminating the underlying hyperthyroidism eliminates the risk of future thyroid storm. Definitive options include:

• Radioactive iodine (RAI): gradual destruction of thyroid tissue; most patients become hypothyroid and require lifelong levothyroxine; the most common definitive treatment in the US
• Total or near-total thyroidectomy: immediate and permanent cure; preferred when a large goiter causes compressive symptoms, when malignancy is suspected, or when the patient desires immediate control
• Long-term antithyroid drug therapy: 18–24 months in Graves disease may induce remission in 30–50% of patients; appropriate if storm risk is low and patient compliance is reliable

Back to Table of Contents

Key Research Papers

1. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263-277 — PubMed PMID: 8325286 — The original paper introducing the Burch-Wartofsky Point Scale — the foundational diagnostic scoring system still universally used to diagnose and stratify thyroid storm severity.
2. Akamizu T, Satoh T, Isozaki O, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Thyroid. 2012;22(7):661-679 — PubMed PMID: 22690898 — Landmark Japanese nationwide survey establishing epidemiology and clinical criteria for thyroid storm in a large contemporary population.
3. Satoh T, Isozaki O, Suzuki A, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society. Endocr J. 2016;63(12):1025-1064 — PubMed PMID: 27746415 — Comprehensive evidence-based management guidelines from the largest national thyroid storm registry, covering diagnosis through definitive treatment.
4. Swee du S, Chng CL, Lim A. Clinical characteristics and outcome of thyroid storm: a case series and review of neuropsychiatric derangements in thyrotoxicosis. Endocr Pract. 2015;21(2):182-189 — PubMed PMID: 25370315 — Case series with systematic review of CNS manifestations in thyroid storm, documenting the spectrum from agitation through psychosis to coma.
5. Angell TE, Lechner MG, Nguyen CT, et al. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endocrinol Metab. 2015;100(2):451-459 — PubMed PMID: 25343237 — Retrospective US cohort study identifying predictors of in-hospital mortality and comparing outcomes by treatment approach in thyroid storm.
6. Chiha M, Samarasinghe S, Kabaker AS. Thyroid storm: an updated review. J Intensive Care Med. 2015;30(3):131-140 — PubMed PMID: 23920160 — Comprehensive review of thyroid storm pathophysiology, diagnosis, and ICU management from an intensive care perspective.
7. Ngo SY, Chew HC. When the storm passes unnoticed — a case series of thyroid storm. Resuscitation. 2007;73(3):485-490 — PubMed PMID: 17291668 — Case series documenting delayed diagnosis of thyroid storm and the consequences of missed or delayed treatment initiation.
8. Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet. 2012;379(9821):1155-1166 — PubMed PMID: 22394559 — Authoritative Lancet seminar on hyperthyroidism in all its forms, including a dedicated discussion of thyroid storm within the broader context of thyrotoxicosis management.
9. Idrose AM. Acute and emergency care for thyrotoxicosis and thyroid storm. Acute Med Surg. 2015;2(3):147-157. — PubMed PMID: 29123713 — Emergency medicine-oriented review covering rapid identification, initial stabilization, and step-by-step acute treatment protocol for thyroid storm in the emergency department setting.
10. Kearney T, Dang C. Diabetic and endocrine emergencies. Postgrad Med J. 2007;83(976):79-86 — PubMed PMID: 17308209 — Practical clinical overview of endocrine emergencies including thyroid storm, written for generalist and emergency physicians.
11. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-382. — PubMed PMID: 24692351 — Comprehensive physiological review of thyroid hormone's role in metabolic regulation — the mechanistic foundation for understanding why storm causes hypermetabolism, hyperthermia, and multi-organ stress.
12. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016;388(10047):906-918. — PubMed PMID: 27038492 — Authoritative Lancet review covering all causes of hyperthyroidism, their natural history, and treatment — providing essential context for understanding the conditions that predispose to thyroid storm.
13. Lee SY, Modzelewski KL, Law AC, Walkey AJ, Pearce EN, Bosch NA. Comparison of Propylthiouracil vs Methimazole for Thyroid Storm in Critically Ill Patients. JAMA Netw Open. 2023;6(4):e238655. — PubMed PMID: 37067797 — Multicentre US cohort of 1,383 patients finding no significant difference in deaths or adverse events between propylthiouracil and methimazole.
14. Taylor P, Okosieme O, Effraimidis G, Gibb F, Parekh D, Moran C, Kopp P, Boelaert K. Management of thyroid emergencies: joint consensus statement on management of thyroid storm. Eur Thyroid J. 2026;15(4). — PubMed PMID: 42554462 — Joint consensus statement reprinting the Burch-Wartofsky Point Scale and covering drug choice, iodine timing and anticoagulation decisions.

PubMed Topic Searches

1. PubMed: Thyroid storm management
2. PubMed: Thyrotoxic crisis treatment
3. PubMed: Burch-Wartofsky score thyroid
4. PubMed: Propylthiouracil thyroid storm
5. PubMed: Thyroid storm plasmapheresis

Back to Table of Contents

Connections

• Endocrinology
• Hyperthyroidism — the underlying condition of excessive thyroid hormone that, when decompensated by an acute trigger, becomes thyroid storm
• Graves Disease — the most common cause of hyperthyroidism and the most frequent underlying condition in patients who develop thyroid storm
• Hashimoto's Thyroiditis — Hashitoxicosis (the transient hyperthyroid phase of Hashimoto's) can occasionally precipitate thyroid storm, particularly early in the disease course
• Thyroid Cancer — thyroidectomy in patients with Graves disease or toxic nodular goiter removes the hormone-producing tissue, definitively preventing future thyroid storm
• Thyroid Disorders — overview of the full spectrum of thyroid disease, including both hypothyroid and hyperthyroid conditions
• Addison's Disease — relative adrenal insufficiency occurs in thyroid storm because accelerated cortisol metabolism outstrips adrenal output; glucocorticoids are mandatory in storm treatment

Back to Table of Contents

Featured Videos